StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
289
Publishing Date
2023 - 07 - 06
2
2022 - 10 - 17
2
2022 - 10 - 06
3
2022 - 09 - 19
2
2022 - 06 - 30
2
2022 - 03 - 16
2
2022 - 03 - 15
5
2022 - 03 - 08
2
2022 - 01 - 24
2
2021 - 11 - 29
3
2021 - 11 - 02
2
2021 - 10 - 28
2
2021 - 10 - 27
3
2021 - 10 - 25
2
2021 - 10 - 21
3
2021 - 10 - 13
2
2021 - 10 - 04
3
2021 - 09 - 29
2
2021 - 09 - 28
2
2021 - 09 - 23
3
2021 - 09 - 22
3
2021 - 09 - 20
4
2021 - 09 - 17
2
2021 - 09 - 13
3
2021 - 08 - 25
4
2021 - 07 - 28
4
2021 - 07 - 22
3
2021 - 07 - 15
3
2021 - 07 - 13
3
2021 - 06 - 30
3
2021 - 06 - 29
4
2021 - 06 - 28
3
2021 - 06 - 24
2
2021 - 06 - 21
3
2021 - 06 - 16
3
2021 - 06 - 15
2
2021 - 06 - 14
3
2021 - 06 - 11
4
2021 - 06 - 09
2
2021 - 06 - 08
3
2021 - 06 - 07
3
2021 - 05 - 20
2
2021 - 05 - 17
2
2021 - 05 - 11
2
2021 - 05 - 10
3
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 04 - 12
2
2021 - 04 - 09
2
2021 - 03 - 31
1
2021 - 03 - 24
3
2021 - 03 - 23
1
2021 - 03 - 22
2
2021 - 03 - 18
1
2021 - 03 - 16
3
2021 - 03 - 11
1
2021 - 03 - 09
1
2021 - 02 - 25
1
2021 - 02 - 02
1
2021 - 01 - 20
1
Sector
Commercial services
8
Communications
1
Consumer non-durables
1
Consumer services
1
Distribution services
1
Electronic technology
1
Finance
2
Health services
4
Health technology
221
Manufacturing
15
Mining, quarrying, and oil and gas extraction
1
N/a
4
Non-energy minerals
4
Producer manufacturing
1
Professional, scientific, and technical services
6
Technology services
1
Transportation and warehousing
1
Tags
Acquisition
518
Agreement
408
Application
255
Biopharma
284
Business
531
Cancer
516
Ceo
237
Collaboration
315
Conference
2748
Contract
244
Corporation
380
Covid
228
Disease
410
Drug
322
Earnings
657
Energy
762
Europe
237
Events
764
Fda
485
Financial
1936
Financial results
1055
Genetown
274
Global
866
Group
391
Growth
743
Health
494
International
271
Management
301
Market
1295
Medical
228
Meeting
385
N/a
24780
Nasdaq
285
Offering
373
Partnership
341
People
335
Pharm-country
255
Pharma
298
Pharmaceutical
258
Pharmaceuticals
528
Phase 2
289
Platform
286
Positive
463
Presentation
438
Program
444
Report
1440
Research
1097
Results
5217
Sales
246
Services
269
Solutions
303
Study
394
System
281
Technology
616
Therapeutics
1467
Therapy
436
Treatment
733
Trial
899
Update
753
Year
838
Entities
Adamis pharmaceuticals corporation
2
Adc therapeutics sa
4
Advaxis, inc.
2
Algernon pharmaceuticals inc.
6
Alnylam pharmaceuticals, inc.
3
Altimmune, inc.
4
Alx oncology holdings inc.
3
Anavex life sciences corp.
7
Anebulo pharmaceuticals inc
2
Annovis bio, inc.
2
Aptinyx inc.
2
Arrowhead pharmaceuticals, inc.
3
Athira pharma, inc.
3
Axsome therapeutics, inc.
2
Ayala pharmaceuticals, inc.
2
Bellus health inc.
3
Biogen inc.
3
Bridgebio pharma, inc.
3
Bristol-myers squibb company
5
Celldex therapeutics, inc.
2
Cerevel therapeutics holdings, inc.
2
Clene inc
7
Eyepoint pharmaceuticals, inc.
2
First wave biopharma, inc.
2
Forma therapeutics holdings, inc.
2
G1 therapeutics, inc.
4
Glaxosmithkline plc
2
Humanigen, inc.
2
I-mab
2
Ideaya biosciences, inc.
3
Immunic, inc.
4
Inmed pharmaceuticals inc.
2
Johnson & johnson
2
Landos biopharma inc
4
Longeveron llc - class a
2
Mediwound ltd.
3
Merck & company, inc.
2
Metacrine, inc.
2
Neogenomics, inc.
2
Novocure limited
3
Ocuphire pharma inc.
4
Otonomy, inc.
4
Palatin technologies, inc.
3
Pds biotechnology corporation
5
Praxis precision medicines, inc.
2
Protagonist therapeutics, inc.
5
Rain therapeutics inc
2
Redhill biopharma ltd.
5
Sage therapeutics, inc.
2
Sanofi
2
Scholar rock holding corporation
3
Seres therapeutics, inc.
2
Springworks therapeutics, inc.
3
Stealth biotherapeutics corp.
2
Surface oncology, inc.
2
Synlogic, inc.
2
Todos medical ltd.
2
Trevi therapeutics, inc.
3
Vbi vaccines, inc.
3
Zai lab limited
4
Symbols
ADCT
4
ADMP
2
ADXS
2
AGNPF
6
ALNY
3
ALT
4
ALXO
3
ANEB
2
ANVS
2
APTX
2
ARWR
3
ATHA
3
AVXL
7
AXSM
2
AYLA
2
BBIO
3
BIIB
3
BLU
3
BMY
5
CERE
2
CLDX
2
CLNN
7
EYPT
2
FMTX
2
FWBI
2
GSK
2
GTHX
4
HGEN
2
IDYA
3
IMAB
2
IMUX
4
INM
2
JNJ
2
LABP
4
LGVN
2
MCRB
2
MDWD
3
MITO
2
MRK
2
MTCR
2
NEO
2
NVCR
3
OCUP
4
OTIC
4
PDSB
5
PRAX
2
PTGX
5
PTN
3
RAIN
2
RDHL
5
SAGE
2
SNY
2
SRRK
3
SURF
2
SWTX
3
SYBX
2
TCON
2
TRVI
3
VBIV
3
ZLAB
4
Exchanges
Amex
8
Nasdaq
264
Nyse
24
Crawled Date
2023 - 07 - 06
2
2022 - 10 - 17
2
2022 - 10 - 06
3
2022 - 09 - 19
2
2022 - 06 - 30
2
2022 - 03 - 16
2
2022 - 03 - 15
5
2022 - 03 - 08
2
2022 - 01 - 24
2
2021 - 11 - 29
3
2021 - 11 - 02
2
2021 - 10 - 28
2
2021 - 10 - 27
3
2021 - 10 - 25
2
2021 - 10 - 21
3
2021 - 10 - 13
2
2021 - 10 - 04
3
2021 - 09 - 29
2
2021 - 09 - 28
2
2021 - 09 - 23
3
2021 - 09 - 22
3
2021 - 09 - 20
4
2021 - 09 - 17
2
2021 - 09 - 13
3
2021 - 08 - 25
4
2021 - 07 - 28
4
2021 - 07 - 22
3
2021 - 07 - 15
3
2021 - 07 - 13
3
2021 - 06 - 30
3
2021 - 06 - 29
4
2021 - 06 - 28
3
2021 - 06 - 24
2
2021 - 06 - 21
3
2021 - 06 - 16
3
2021 - 06 - 15
2
2021 - 06 - 14
3
2021 - 06 - 11
4
2021 - 06 - 09
2
2021 - 06 - 08
3
2021 - 06 - 07
3
2021 - 05 - 20
2
2021 - 05 - 17
2
2021 - 05 - 11
2
2021 - 05 - 10
3
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 04 - 12
2
2021 - 04 - 09
2
2021 - 03 - 31
1
2021 - 03 - 24
3
2021 - 03 - 23
1
2021 - 03 - 22
2
2021 - 03 - 18
1
2021 - 03 - 16
3
2021 - 03 - 11
1
2021 - 03 - 09
1
2021 - 02 - 25
1
2021 - 02 - 02
1
2021 - 01 - 20
1
Crawled Time
00:00
44
00:20
10
01:00
31
02:00
4
03:00
5
04:00
3
05:00
9
06:00
19
07:00
25
08:00
10
08:20
2
09:00
9
10:00
12
11:00
108
11:01
2
12:00
289
12:01
7
12:03
11
12:11
2
12:15
57
12:20
51
12:30
37
12:39
2
13:00
203
13:01
7
13:02
3
13:03
9
13:05
4
13:11
2
13:15
34
13:20
38
13:26
2
13:30
55
13:35
6
13:59
2
14:00
158
14:01
8
14:03
3
14:05
2
14:15
16
14:20
16
14:30
17
14:47
2
15:00
103
15:15
2
15:20
4
15:30
13
16:00
43
16:20
21
17:00
32
18:00
37
18:16
4
19:00
30
20:00
42
20:20
7
21:00
53
21:02
3
22:00
65
22:15
3
23:00
32
Source
ir.akerotx.com
1
nouveaumonde.ca
1
ocutx.gcs-web.com
1
www.anavex.com
3
www.athira.com
1
www.biospace.com
155
www.curevac.com
1
www.eyegatepharma.com
1
www.globenewswire.com
98
www.prnewswire.com
24
www.vbivaccines.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Phase 2
crawled time :
12:00
save search
Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation
Published:
2023-12-04
(Crawled : 12:00)
- globenewswire.com
APLM
|
$0.531
-1.69%
-1.71%
100K
|
n/a
|
-42.69%
|
O:
2.53%
H:
0.22%
C:
-17.21%
ongoing
trials
phase 2
Telesat Government Solutions Awarded DARPA Space-BACN Phase 2 Contract
Published:
2023-11-29
(Crawled : 12:00)
- globenewswire.com
TSAT
|
$7.97
0.63%
0.63%
27K
|
|
-27.89%
|
O:
0.28%
H:
5.81%
C:
3.46%
contract
solutions
phase 2
Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion
Published:
2023-11-28
(Crawled : 12:00)
- globenewswire.com
SKYE
|
$9.17
-20.98%
27K
|
Transportation and Warehousing
|
1020.0%
|
O:
3.23%
H:
6.25%
C:
-3.13%
sbi-100
glaucoma
bioscience
study
phase 2
Akoustis Awarded Phase 2 For DARPA COFFEE Program
Published:
2023-11-16
(Crawled : 12:00)
- globenewswire.com
AKTS
|
$0.5048
-0.06%
-0.06%
360K
|
Electronic Technology
|
-33.18%
|
O:
9.51%
H:
0.27%
C:
-16.89%
program
phase 2
Celldex Therapeutics Announces Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria
Published:
2023-11-06
(Crawled : 12:00)
- globenewswire.com
CLDX
|
News
|
$39.66
2.75%
2.67%
910K
|
Health Technology
|
49.87%
|
O:
26.94%
H:
1.73%
C:
-11.01%
urticaria
positive
topline
therapeutics
results
study
phase 2
Ocuphire Pharma Announces Successful End-of-Phase 2 Meeting with FDA for Oral APX3330 in Diabetic Retinopathy
Published:
2023-11-02
(Crawled : 12:00)
- globenewswire.com
OCUP
|
$1.745
0.29%
0.29%
92K
|
Health Technology
|
-39.37%
|
O:
5.23%
H:
2.65%
C:
-8.94%
apx3330
fda
pharma
meeting
diabetic
phase 2
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
Published:
2023-10-31
(Crawled : 12:00)
- globenewswire.com
LIFE
|
$1.59
-1.24%
-1.26%
540K
|
Health Technology
|
27.2%
|
O:
-0.8%
H:
2.42%
C:
0.81%
pharma
efzofitimod
study
phase 2
Hycroft Mining Finds Elevated Silver Across the Hycroft System in Phase 2 Drilling
Published:
2023-10-23
(Crawled : 12:00)
- prnewswire.com
HYMC
|
$3.69
-1.86%
-1.9%
550K
|
Non-Energy Minerals
|
20.17%
|
O:
2.31%
H:
4.6%
C:
4.6%
system
mining
phase 2
HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME
Published:
2023-10-05
(Crawled : 12:00)
- prnewswire.com
ZYNE
|
$1.3
3.08%
860K
|
Health Technology
|
2.77%
|
O:
-3.56%
H:
4.1%
C:
2.46%
HRMY
|
$29.19
-1.98%
-2.02%
330K
|
Health Technology
|
-8.15%
|
O:
0.41%
H:
1.63%
C:
1.03%
study
phase 2
Zevra Therapeutics Announces Interim Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
Published:
2023-10-02
(Crawled : 12:00)
- globenewswire.com
ZVRA
|
$4.66
-2.31%
-2.36%
210K
|
n/a
|
-3.73%
|
O:
0.0%
H:
0.83%
C:
-2.07%
kp1077
trial
therapeutics
phase 2
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
Published:
2023-09-18
(Crawled : 12:00)
- globenewswire.com
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
|
801.57%
|
O:
2.36%
H:
6.15%
C:
-1.46%
pharmaceuticals
trial
phase 2
Altimmune Announces Completion of Dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight
Published:
2023-09-12
(Crawled : 12:00)
- globenewswire.com
ALT
|
$7.05
-6.25%
-6.67%
3.6M
|
Commercial Services
|
209.47%
|
O:
0.82%
H:
7.76%
C:
6.53%
obesity
momentum
trial
phase 2
4DMT Announces First Patient Enrolled in 4D-150 Phase 2 SPECTRA Clinical Trial in DME, and Expansion of 4D-150 Phase 2 Stage in PRISM Clinical Trial in Wet AMD
Published:
2023-09-07
(Crawled : 12:00)
- globenewswire.com
FDMT
|
$25.3
-5.42%
-5.73%
520K
|
Health Technology
|
59.62%
|
O:
-1.39%
H:
2.5%
C:
1.02%
prism
expansion
trial
phase 2
Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
Published:
2023-08-23
(Crawled : 12:00)
- globenewswire.com
ONVO
|
$1.165
1.3%
1.29%
540K
|
Health Technology
|
-13.18%
|
O:
6.98%
H:
0.0%
C:
-1.45%
fxr314
nash
phase 2
Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
Published:
2023-08-17
(Crawled : 12:00)
- biospace.com/
IMUX
|
$1.225
-4.3%
-4.49%
180K
|
Health Technology
|
-26.67%
|
O:
1.82%
H:
1.23%
C:
-4.76%
sclerosis
trial
phase 2
Eloxx Pharmaceuticals Reports Drug Response in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome
Published:
2023-08-14
(Crawled : 12:00)
- globenewswire.com
ELOX
|
$0.9874
-51.57%
93K
|
Health Technology
|
-79.21%
|
O:
5.05%
H:
20.04%
C:
14.83%
elx-02
drug
pharmaceuticals
response
study
phase 2
Palisade Bio Announces Topline Results from U.S. Phase 2 PROFILE Study Evaluating LB1148 for Post-Surgical Abdominal Adhesions
Published:
2023-08-09
(Crawled : 12:00)
- globenewswire.com
PALI
|
$6.54
10.29%
9.33%
1.6M
|
Manufacturing
|
240.21%
|
O:
-69.07%
H:
22.78%
C:
20.62%
lb1148
topline
results
study
phase 2
Bolt Biotherapeutics Initiates Phase 2 Clinical Studies of BDC-1001 in Patients With HER2-Positive Cancer
Published:
2023-08-03
(Crawled : 12:00)
- biospace.com/
BOLT
|
$1.12
-2.61%
-2.68%
74K
|
|
-11.54%
|
O:
0.77%
H:
3.82%
C:
0.0%
bdc-1001
cancer
phase 2
Humacyte Completes Enrollment in Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) for Vascular Trauma Repair
Published:
2023-07-26
(Crawled : 12:00)
- globenewswire.com
HUMA
|
$3.13
2.29%
2.24%
1.1M
|
Manufacturing
|
8.71%
|
O:
0.0%
H:
3.83%
C:
1.39%
trial
phase 2
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis
Published:
2023-07-06
(Crawled : 12:00)
- globenewswire.com
CLDX
|
News
|
$39.66
2.75%
2.67%
910K
|
Health Technology
|
10.71%
|
O:
-0.54%
H:
2.14%
C:
1.4%
study
phase 2
← Previous
1
2
3
4
5
6
7
8
9
…
14
15
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.